Insomnia or Sleep Apnea? Why Midlife Women Get Missed
Last reviewed: 09/17/2026
Reviewed by: Dr. Kiesa Kelly
You wake at three in the morning, and have for months. You do not snore, or not that anyone has mentioned. You are tired in a heavy, cognitive way rather than a falling-asleep-at-the-wheel way. Someone has probably told you this is what midlife does.
Here is the tension. The question "is it insomnia or sleep apnea?" is usually answered with a symptom list that describes men: loud snoring, a partner reporting pauses in breathing, falling asleep during the day. If those are the tells, a midlife woman sleeping alone with a fragmented night and a foggy morning fails the test — not because she does not have sleep apnea, but because the test was not built to find it in her. And the standard advice, treat the insomnia, is not wrong so much as incomplete.
In this article, you'll learn:
Why sleep apnea in women often presents as insomnia rather than snoring
What sleep studies actually show about apnea risk after menopause, including the findings that disagree
Why the common screening questionnaires perform worse in women, with the numbers
How the criterion that gates home sleep testing encodes a symptom pattern many women cannot meet
What to do when insomnia and sleep apnea are both present, which is more common than either alone suggests
Specific questions to bring to a clinician, and the symptoms that warrant asking sooner
The short answer: this is usually not a fork in the road
Most articles frame this as a choice between two diagnoses. That framing is the first thing to let go of.
Insomnia and obstructive sleep apnea co-occur often enough to have their own name in the literature — COMISA, comorbid insomnia and sleep apnea. A 2026 systematic review and meta-analysis pooling 16 studies put the prevalence at roughly 30% [1]. That is not a rare overlap at the edges of two conditions. That is close to a third of the people asking this question having both.
So the useful question is not "which one is it." It is "has anyone actually checked the breathing question, or did the conversation stop at insomnia because insomnia is what you described?" Those have very different answers, and only one of them requires a sleep study. If a screener has already flagged your sleep — the PROMIS-29 sleep-disturbance items are a common place this surfaces — that is a starting point for the conversation, not an answer to it.
🧩 Key takeaway: Insomnia and sleep apnea co-occur in roughly 30% of cases in pooled data, so treating "either/or" as the starting question is what causes the miss.
Three things midlife women get told, and what the evidence says
These come up often enough in insomnia care to be worth naming directly.
"You would know if you had sleep apnea — you don't snore." Snoring is one presentation, not the definition. A 2026 review of sleep apnea in women describes a pattern built on partial obstructions and arousals rather than dramatic oxygen drops — sleep fragmentation the apnea-hypopnea index was not designed to capture [2]. The night is badly fragmented while the classic noises stay mild or absent. What reaches awareness is the waking, not the breathing.
"It's menopause. It will settle." Some of it may, and perimenopausal insomnia is genuinely treatable on its own terms. But this is exactly what the longitudinal research warns against. Authors who followed 219 midlife women through 1,667 sleep studies wrote that attributing any sleep problem to normal processes of menopause may lead to underdiagnosis of treatable sleep disorders [3]. "It's menopause" describes timing. It is not a diagnosis.
"My sleep study was normal, so it isn't apnea." Sometimes true, sometimes premature. Current American Academy of Sleep Medicine guidance says that if a single home test is negative, inconclusive, or technically inadequate, a full in-lab study should follow — and it suggests considering a second study when suspicion persists [4]. A clean home test is one measurement, not a closed file.
🔍 Key takeaway: A negative home sleep test with ongoing symptoms is, by the guideline's own text, a reason for a more thorough study — not a reason to stop.
What actually changes after menopause
The honest answer here is more interesting than a clean one.
A population study that put more than two thousand adults through full overnight polysomnography found sleep-disordered breathing above 5 events per hour in 35.1% of premenopausal women and 71.6% of postmenopausal women. Above 15 events, the figures were 8.6% and 29.4% [5]. The gap widens as severity rises.
A long-running cohort study adjusted for age, body habitus, and smoking. It found the odds about 2.6 times higher after menopause at the lower threshold, and about 3.5 times higher at the upper one. The perimenopausal odds ratios were not statistically significant [6]. The clear signal is after menopause, not during the transition.
The evidence is also not unanimous. A longitudinal analysis from the Study of Women's Health Across the Nation repeated sleep studies on 159 women about three and a half years apart and found no change in the apnea-hypopnea index by transition group [7].
That disagreement is worth stating plainly. Risk is higher after menopause; the transition itself is the ambiguous zone. "Menopause causes sleep apnea" is stronger than the evidence supports.
Why it may rise is less settled still. Body composition is the piece with the most direct support: in a national survey sample, visceral fat measured by body-composition scanning accounted for part of the link between menopausal status and self-reported sleep-apnea symptoms, independently of body mass index [8] — so where fat sits appears to matter, not only how much there is. That study asked about symptoms rather than measuring breathing overnight, which is a real limit given how poorly symptom questions perform in women. The hormonal explanation is thinner still. A study of 24 women found airway-dilating muscle activity highest in the luteal phase and lowest after menopause [9], but upper airway resistance did not actually differ between groups. The step from there to "declining progesterone collapses the airway" is an inference the literature has not closed.
If you are weighing hormone therapy, that belongs with the clinician who prescribes it. There is no good trial evidence that it treats sleep apnea, and this is not the page to steer that decision.
🌡️ Key takeaway: Apnea risk is measurably higher after menopause in the population studies that measured it directly, but the mechanism is unsettled and the transition itself is ambiguous.
Why sleep apnea gets missed in women
This is where the differential actually lives.
The symptoms do not match the picture
Consider a 54-year-old waking between two and four most nights, for most of a year. She does not remember waking gasping. She remembers waking hot, or with her heart going, or for no reason she can name, and then lying there. Mornings start with a dull headache that coffee resolves. By mid-afternoon her recall is off, and she has started keeping notes in meetings she would not have needed two years ago. Her husband says she snores lightly and sleeps through it. She has described all of this to two clinicians as "insomnia," because that is the word that fits what she experiences.
Or: a 58-year-old who has lived alone for six years. No one can report what happens while she sleeps, so the single item that does much of the work on the common apnea screeners — has anyone witnessed you stop breathing — has no answer she can give, and answering "no" is not the same as it being absent. She is exhausted in a way that reads to her as depression, and she has wondered whether that is what it is. Fragmented sleep and low mood do feed each other, and a depression screener is reasonable to complete alongside a sleep evaluation — not instead of one. Her fatigue has been treated twice. Her sleep has never been measured.
Both are recognizable presentations of sleep-disordered breathing. Neither looks like the symptom list.
The 2026 review puts it plainly: women more often report daytime fatigue, insomnia, depression, anxiety, and poor sleep quality rather than sleepiness or snoring, which may lead to fewer sleep clinic referrals [2]. The same review identifies sleep-maintenance insomnia as itself a possible clue to underlying sleep-disordered breathing — because respiratory events and the arousals they trigger produce the awakenings that patients then experience, and describe, as insomnia [2].
The distinguishing pattern: insomnia costs are about what happens after you wake — the mind switching on, the clock arithmetic, the learned association between the bed and being awake, which is the mechanism behind sleep-maintenance insomnia and the 3 a.m. waking pattern. Apnea costs are about what happens while you sleep — fragmentation you never consciously register, showing up as unrefreshing sleep, morning headache, and daytime cognitive drag rather than as a struggle to fall asleep.
The questionnaires were built on men
This is not a soft claim. It has been measured repeatedly.
In a population study of 1,809 adults who all had home sleep testing, one widely used questionnaire achieved 87.1% sensitivity in men and 55.3% in women for moderate-to-severe disease; the same sex gap appeared with STOP-Bang. Women-specific cutoffs raised sensitivity in women to roughly 88% [10].
A cross-sectional study of 1,978 women with a mean age of 55 measured how well three common instruments discriminated moderate-to-severe apnea: the Epworth Sleepiness Scale produced an area under the curve of 0.53, the Berlin questionnaire 0.58, and STOP-Bang 0.67 [11]. An area under the curve of 0.53 is very close to a coin flip — and the Epworth is the instrument most likely to be used to decide whether a midlife woman is sleepy enough to be worth referring. A study in midlife women specifically found STOP-Bang at a threshold of 3 gave 77% sensitivity and 45% specificity, with a discrimination estimate whose confidence interval ran from 0.51 to 0.84 — a lower bound barely distinguishable from a coin flip [12]. Its authors concluded that a lower score may still be predictive of more severe disease in women, and that a lower threshold should trigger further testing [12]. In postmenopausal women, one prediction index reached 98% sensitivity at the lowest threshold but fell to 32% at a more meaningful one [13].
The structural reason is not subtle. Several of these instruments count male sex as a risk point and use neck-circumference thresholds drawn mainly from male populations, which the 2026 review notes may paradoxically lower their performance in women [2].
The home-testing criterion has the same problem
This is the part most worth carrying away, because it is not an opinion about clinical culture. It is in the guideline.
The AASM's diagnostic testing guideline defines increased risk of moderate to severe sleep apnea — the criterion that gates the home sleep apnea testing route — as excessive daytime sleepiness and at least two of habitual loud snoring, witnessed apnea or gasping or choking, or diagnosed hypertension [4].
Read that against the two women above. It requires daytime sleepiness, which many women experience and describe as fatigue. Then it requires two of three features from the classic presentation — one of which, witnessed apnea, a woman sleeping alone structurally cannot report. A midlife woman with sleep-maintenance insomnia, fatigue rather than frank sleepiness, and quiet snoring can fail this criterion while having moderate disease.
One thing worth knowing before you read that as a closed door: this criterion governs which test is appropriate, not whether you should be evaluated at all. The same guideline's foundational statement is that polysomnography is the standard diagnostic test for adults in whom there is a concern for sleep apnea based on a comprehensive sleep evaluation [4]. The entry point is a clinician's assessment, not a three-item checklist.
There is a second, narrower opening in the same document. Severe insomnia appears on the guideline's list of conditions for which an in-lab study should be used instead of a home test [4]. That is a reason to ask which test you are being offered. It is not, on its own, the guideline saying you should be tested.
📋 Key takeaway: The criterion that gates home sleep testing requires a witnessed event a woman sleeping alone cannot supply — but that criterion decides which test, not whether you get evaluated. The guideline's own entry point is a clinician's comprehensive sleep evaluation.
When insomnia is the presenting complaint
If roughly 30% of this population has both conditions [1], then the practical question is what order to do things in. Two things are worth separating: when the breathing question gets evaluated, and in what order the two conditions get treated. The evaluation does not have to wait for anything. The treatment order has actual trial evidence behind it.
A randomized controlled trial of 145 adults with both sleep apnea and comorbid insomnia gave one group four sessions of cognitive behavioral therapy for insomnia before starting CPAP and the other group CPAP as usual. At six months, the group that had done CBT-I first used their CPAP an average of 61 minutes more per night, and initial acceptance of CPAP was 99% versus 89% [14]. Treating the insomnia made the apnea treatment work better.
Response to behavioral treatment may be less complete when apnea is also present, though the evidence here is thinner than it sounds. In a retrospective study of 131 veterans with both conditions — 85% of them men — average insomnia severity fell substantially after brief behavioral therapy, but 43% did not reach the study's threshold for response [15]. There was no insomnia-only comparison group, so that is a description of how one mostly-male sample did, not a measured penalty for having apnea. It is a reason to find out whether apnea is present, not a reason to skip behavioral treatment — and it is not evidence that CBT-I is unsafe when apnea is undiagnosed. Current clinical guidance for this overlap recommends multidisciplinary, patient-centered care rather than sequencing one treatment behind the other [17].
Mechanism matters here, because the two treatments do different jobs. Behavioral treatment changes what your sleep system does after an awakening — the conditioned arousal, the time in bed, the learned association between bed and wakefulness. It does not change whether your airway obstructs. Positive airway pressure changes whether your airway obstructs. It does not undo a year of conditioned arousal. Someone with both who treats only one will improve partway and reasonably conclude that nothing works.
🔋 Key takeaway: Behavioral treatment addresses what happens after you wake; airway treatment addresses what happens while you sleep. Treating one when you have both produces a partial answer.
Which path fits your situation
None of what follows can tell you whether your airway obstructs at night — only a sleep study does that, and the AASM's guidance is explicit that questionnaires and rules of thumb should not be used to diagnose sleep apnea [4]. What these can do is tell you what to raise first.
If your main problem is falling asleep, your nights are otherwise unbroken, and you wake reasonably restored, insomnia is the sensible place to start, and behavioral treatment is the first-line answer. That is where to begin, not a reason to rule the breathing question out.
If your main problem is staying asleep, mornings are unrefreshing regardless of hours, and there is a headache on waking or cognitive drag out of proportion to your time in bed, ask for the breathing question to be evaluated now — not after behavioral treatment has been tried and found partly effective.
If both fit, that is the common case, not the confusing one. Say so at the appointment, and ask for both to be on the plan rather than one waiting on the other's outcome.
If anyone told you it is menopause and left it there, treat that as an unfinished conversation. Specialized therapy for sleep can begin while the medical question is still open, and a general mental health screener can clarify whether mood or anxiety is also in the picture — though only a sleep study answers the breathing question.
What to ask
Concrete questions, worth asking verbatim:
"Given that I sleep alone and cannot report witnessed apneas, what are you using to decide which sleep test I should have?" This surfaces the criterion problem directly, without accusation.
"If my insomnia is severe, does that make an in-lab study more appropriate than a home test for me?" The guideline's own text supports asking [4].
"If my home test comes back negative and I still feel this way, what is the next step?" Settling this in advance stops a negative result from ending the conversation.
"What did my study measure, and how were partial obstructions scored?" Hypopneas are scored against thresholds for how far oxygen saturation drops or whether an arousal occurred. Because women's events skew toward partial obstructions with borderline desaturations, that choice is not a trivial detail. It is a question for the physician reading your study.
"Can we work on the insomnia while the apnea question is evaluated?" The trial evidence suggests this ordering helps [14].
When to ask sooner rather than later
Most of this moves at the pace of a normal appointment. Some of it should not.
Ask for prompt evaluation if there is witnessed gasping, choking, or pauses in breathing. Ask promptly too if you have significant heart or lung disease, a history of stroke, or take chronic opioid medication — the guideline lists all of these as reasons to choose in-lab testing [4]. And ask promptly if you are falling asleep unintentionally during the day, particularly while driving.
This matters beyond comfort because the cardiovascular association is real. A prospective cohort found an adjusted odds ratio for hypertension of 1.42 even below the diagnostic threshold, at 0.1 to 4.9 events per hour [16] — though that estimate comes from a mixed-sex cohort. In the population polysomnography cohort above, severity was significantly associated with hypertension in women, mainly postmenopausal women, and fell just short of significance in men; the authors concluded the association was present in women [5].
❤️ Key takeaway: In a population sleep-study cohort, the hypertension association reached significance in women. That makes this a cardiovascular question, not only a tiredness one.
Where to go from here
If you have been describing your nights as insomnia and no one has asked about your breathing, make the breathing question explicit — in the same appointment, not the next one. If you were told a study was normal and you still feel the way you feel, the guideline supports asking what comes next.
And if both pieces are in play, that is not a complication. It is the ordinary shape of this problem, and there is a sensible order to work in.
Sleep not coming easily?
CBT-I is the first-line, evidence-based treatment for chronic insomnia — a clinician can help you rebuild sleep without relying on medication alone.
Frequently Asked Questions
Can sleep apnea feel like insomnia rather than snoring?
Yes, and in women it often does. Breathing events fragment sleep and trigger arousals, and what reaches awareness is waking repeatedly and struggling to fall back asleep rather than gasping or choking. A 2026 review in Pulmonary Therapy notes that sleep-maintenance insomnia can itself be a clinical clue pointing toward underlying sleep-disordered breathing, which is the opposite of how most symptom lists are organized.
My sleep study came back normal but I still feel terrible. what now?
A negative study does not always close the question. Current AASM guidance says that if a single home sleep apnea test is negative, inconclusive, or technically inadequate, an in-lab sleep study should be performed, and it suggests considering a second study when clinical suspicion remains after a negative one. Women's breathing events also skew toward partial obstructions and arousals rather than large oxygen drops, which the standard index was not designed to capture. Bring both points to your sleep physician.
Why do the sleep apnea questionnaires seem to miss women?
Because several of them count male sex as a risk point and use neck-size thresholds drawn largely from men. In a study of 1,809 adults with home sleep testing, one widely used questionnaire reached 87.1% sensitivity in men but only 55.3% in women at moderate-to-severe disease. Sex-specific cutoffs raised sensitivity in women to roughly 88%. A low score is weaker evidence against apnea in a woman than most people assume.
Should I start CBT-I or get tested for sleep apnea first?
Often both, rather than one then the other. Insomnia and sleep apnea co-occur frequently, and a randomized trial found that people who completed CBT-I before starting CPAP used it about an hour more per night than those who started CPAP alone. We can begin behavioral treatment for the insomnia while a sleep physician evaluates the breathing question, and neither has to wait for the other.
Does treating the insomnia mean I can skip the sleep study?
No. Behavioral treatment addresses how your sleep system responds after an awakening, not whether your airway is obstructing during the night. Untreated sleep apnea carries cardiovascular risk that improving your sleep habits will not change, and in one population sleep-study cohort the association between sleep-disordered breathing and hypertension reached significance in women, mainly postmenopausal women. The two questions are separate and both worth answering.
About the Author
Dr. Kiesa Kelly is a licensed clinical psychologist with more than 20 years of experience in psychological assessment and evidence-based treatment. Her clinical training includes work at the University of Chicago, Vanderbilt University, and the University of Wisconsin, and her practice focuses on adults navigating conditions that are frequently missed or misattributed — including the sleep, mood, and attention changes that surface in midlife.
Dr. Kelly founded ScienceWorks Behavioral Healthcare to provide assessment and therapy that account for how conditions actually present in adults, rather than how older diagnostic pictures assumed they would. She reviews every clinical article published here for accuracy before it goes live.
References
1. Cotrik E, Hernandes J, Castro V, Zancanella E. Physiopathological correlations of comorbid insomnia and sleep apnoea (COMISA) — a systematic review and meta-analysis. Sleep and Breathing. 2026;30(2):101. https://pubmed.ncbi.nlm.nih.gov/41863735/
2. Bouloukaki I, Fabozzi A, Schwarz EI, Schiza SE. Advances in the Diagnosis and Treatment of Obstructive Sleep Apnea in Women. Pulmonary Therapy. 2026;12(1):181–199. https://pmc.ncbi.nlm.nih.gov/articles/PMC12992857/
3. Mirer AG, Young T, Palta M, Benca RM, Rasmuson A, Peppard PE. Sleep-disordered breathing and the menopausal transition among participants in the Sleep in Midlife Women Study. Menopause. 2017;24(2):157–162. https://pmc.ncbi.nlm.nih.gov/articles/PMC5266663/
4. Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. 2017;13(3):479–504. https://pmc.ncbi.nlm.nih.gov/articles/PMC5337595/
5. Heinzer R, Marti-Soler H, Marques-Vidal P, et al. Impact of sex and menopausal status on the prevalence, clinical presentation, and comorbidities of sleep-disordered breathing. Sleep Medicine. 2018;51:29–36. https://pubmed.ncbi.nlm.nih.gov/30081384/
6. Young T, Finn L, Austin D, Peterson A. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. American Journal of Respiratory and Critical Care Medicine. 2003;167(9):1181–1185. https://pubmed.ncbi.nlm.nih.gov/12615621/
7. Matthews KA, Lee L, Kravitz HM, et al. Influence of the menopausal transition on polysomnographic sleep characteristics: a longitudinal analysis. Sleep. 2021;44(11):zsab139. https://pmc.ncbi.nlm.nih.gov/articles/PMC8598193/
8. Wang Y, Liu H, Zhou B, Yue W, Wang M, Hu K. Menopause and obstructive sleep apnea: revealing an independent mediating role of visceral fat beyond body mass index. BMC Endocrine Disorders. 2025;25(1):21. https://pmc.ncbi.nlm.nih.gov/articles/PMC11765922/
9. Popovic RM, White DP. Upper airway muscle activity in normal women: influence of hormonal status. Journal of Applied Physiology. 1998;84(3):1055–1062. https://pubmed.ncbi.nlm.nih.gov/9480969/
10. Bauters FA, Loof S, Hertegonne KB, Chirinos JA, De Buyzere ML, Rietzschel ER. Sex-specific sleep apnea screening questionnaires: closing the performance gap in women. Sleep Medicine. 2020;67:91–98. https://pubmed.ncbi.nlm.nih.gov/31918123/
11. Ginetti MB, Franzoy J, Perri M, et al. Crossectional Study on the Performance of Screening Questionnaires for Prediction of Moderate to Severe Obstructive Sleep Apnea in Women. Sleep Science. 2024;17(3):e289–e296. https://pmc.ncbi.nlm.nih.gov/articles/PMC11390166/
12. Orbea CAP, Lloyd RM, Faubion SS, Miller VM, Mara KC, Kapoor E. Predictive ability and reliability of the STOP-BANG questionnaire in screening for obstructive sleep apnea in midlife women. Maturitas. 2020;135:1–5. https://pmc.ncbi.nlm.nih.gov/articles/PMC7644815/
13. Morris JL, Orbell S, Scott PW, et al. Risk stratification by sex and menopausal status in the multivariable apnea prediction index. Sleep and Breathing. 2023;27(5):1695–1702. https://pubmed.ncbi.nlm.nih.gov/36571709/
14. Sweetman A, Lack L, Catcheside PG, et al. Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clinical trial. Sleep. 2019;42(12):zsz178. https://pubmed.ncbi.nlm.nih.gov/31403168/
15. El-Solh AA, Martinson A, Attai P, Homish G, Aibangbee K, Gould E. Determinants of treatment response to cognitive behavioral therapy in veterans presenting with comorbid insomnia and sleep apnea. Sleep and Breathing. 2025;29(2):129. https://pmc.ncbi.nlm.nih.gov/articles/PMC11909029/
16. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. New England Journal of Medicine. 2000;342(19):1378–1384. https://pubmed.ncbi.nlm.nih.gov/10805822/
17. Ong JC, Crawford MR, Wallace DM. Sleep Apnea and Insomnia: Emerging Evidence for Effective Clinical Management. Chest. 2021;159(5):2020–2028. https://pmc.ncbi.nlm.nih.gov/articles/PMC8129729/
Disclaimer
This article is for informational purposes only and is not a substitute for individualized medical or psychological care. It does not diagnose any condition and does not provide guidance on medication or hormone therapy. Obstructive sleep apnea is diagnosed by a sleep study ordered and interpreted by a qualified physician; no questionnaire or article can diagnose it. If you are concerned about your sleep or your health, talk with a licensed clinician about your specific situation.